KRAS mutation + EGFR wild-type
|
NSCLC
|
KRAS mutation + EGFR wild-type
|
NSCLC
|
docetaxel Resistant: D – Preclinical
|
docetaxel Resistant: D – Preclinical
|
KRAS mutation + EGFR wild-type
|
NSCLC
|
KRAS mutation + EGFR wild-type
|
NSCLC
|
5-fluorouracil Resistant: D – Preclinical
|
5-fluorouracil Resistant: D – Preclinical
|